Ultralife (NASDAQ:ULBI - Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Tuesday, March 11th. Analysts expect Ultralife to post earnings of $0.23 per share and revenue of $40.00 million for the quarter. Persons interested in listening to the company's earnings conference call can do so using this link.
Ultralife Trading Up 0.8 %
NASDAQ:ULBI traded up $0.05 during trading hours on Friday, reaching $6.06. 20,005 shares of the stock were exchanged, compared to its average volume of 75,239. Ultralife has a twelve month low of $5.79 and a twelve month high of $13.39. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average of $7.30 and a two-hundred day moving average of $8.25. The company has a market capitalization of $100.76 million, a price-to-earnings ratio of 11.02 and a beta of 1.05.
Analyst Upgrades and Downgrades
Separately, Benchmark restated a "buy" rating and set a $14.00 target price on shares of Ultralife in a report on Friday, November 15th.
View Our Latest Analysis on Ultralife
Institutional Investors Weigh In On Ultralife
An institutional investor recently raised its position in Ultralife stock. Bank of America Corp DE lifted its stake in shares of Ultralife Co. (NASDAQ:ULBI - Free Report) by 30.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,067 shares of the technology company's stock after acquiring an additional 2,836 shares during the quarter. Bank of America Corp DE owned 0.07% of Ultralife worth $90,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 30.68% of the company's stock.
Ultralife Company Profile
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading

Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.